Clinical

Discover results-proven tools and methodologies for your clinical development. Learn how to improve your trial design, data collection and clinical supply. In addition, get key information on how to improve your patient recruitment and retention. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in clinical development to exchange ideas on best practice and share case studies on innovation within the area.
 

Fleeing India: What Will Make Clinical Trials Flood Back

Contributor: Ghida Harfouche
Posted: 8/11/2014

Fleeing India: What Will Make Clinical Trials Flood Back - Ghida Harfouche

India’s clinical trial industry has seen it all. In less than 10 years, the country has grown to become a leading destination for clinical trials, attracting studies from multinational pharma companies and contract research organizations. This however is no longer the case as the once skyrocket growth has now come to a brutal end. If India’s clinical trial industry is to pick up again, a major restructuring of its regulatory system will have to take place. Full Article »


Events related to this topic:

Experiences with IRT- An Interview with CTS manager Michael Pompey

Contributor: Michael Pompey
Posted: 10/22/2013


Experiences with IRT- An Interview with CTS manager Michael Pompey - Michael Pompey

Ahead of the Clinical Trial Supply Europe event, Pharma IQ presents interviews filmed live at last year's CTS event. In this interview Michael Pompey talks about the daily challenges he faces as a clinical trial supply manager at Sandoz and he discusses his experience with IRT. Full Video »


Events related to this topic:

Epigenetic Cancer Therapies and the TOPAS Trial- An Interview with Hella Kohlhof - Gerald Clarke

For Dr Hella Kohlhof, the study of epigenetics was not love at first sight, however the potential it posesses eventually won her over. Now Dr Kohlhof is Manager of Translational Pharmacology at 4SC AG and is applying epigenetic knowledge in a phase 1 first-in-man trial. She talks to us about what role epigentics plays in cancer and how new therapies are taking advantage of epigenetic mechanisms. Full Podcast »


Events related to this topic:

Seems Everyone Is Building Clinical Data Repositories, Now How Are We Going To Use Them? - Robert Musterer

Whether you call it a clinical data repository (CDR) or a clinical data warehouse (CDW); it seems everyone (oh, all right - at least a lot of companies) are either building, or planning to build one. Most of these companies have grand notions of bringing together data from a wide variety of sources to be able to glean new insights. However the big unanswered questions are; just how are these insights to be gleaned, and who will be doing the searching to glean these insights? Full Column »


Events related to this topic:

Which Popular Drugs Are Going Off-Patent in 2014-2016?

Now that we’re at the edge of the cliff, do you know which blockbusters will be going off patent in the next 3 years? By popular request, Pharma IQ has put together a handy snapshot of all the top drugs facing imminent generic competition. Full Whitepaper »


Events related to this topic:



Advertise With Us

Join the Pharmas IQ Community